BioElectronics, in pulsed therapy deal:
This article was originally published in Clinica
BioElectronics (Frederick, Maryland) has signed an agreement with Barron Medical, a distributor of medical equipment headquartered in Chino Hills, California, to distribute its ActiPatch electromagnetic therapy technology in the US. The two companies will combine to bring the drug-free anti-inflammatory patch to a market of 200 million soft tissue injuries in the US every year. The product administers "weeks of continuous pulsed therapy for less than a dollar a day", claims BioElectronics.
You may also be interested in...
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.